Los puntos clave no están disponibles para este artículo en este momento.
CAP is very efficient to detect even low grade steatosis. CAP being implemented on FibroScan(®) (Echosens, Paris, France), both steatosis and fibrosis can be evaluated simultaneously, enlarging the spectrum of non-invasive techniques for the management of chronic liver diseases.
Lédinghen et al. (Wed,) studied this question.